Skip navigation

Calls to Action

Science

October 14, 2007

April 10, 2007 

 

This month autism is featured in a new in-depth article in the April issue of Discover magazine. In "Autism: It's Not Just in the Head," reporter Jill Neimark provides an analysis of a few of the latest developments and concepts in autism research. The article focuses on how autism, often thought of as simply a brain disorder, is now being investigated by some researchers as a more general disorder that may also affect the immune and gut systems.

 

Archive
Autism Speaks, Science, Latest Research
Trial demonstrates that caregivers can effectively teach joint engagement skills
January 12, 2011

Archive
Do you see what I see? | 2010 Top 10
Test Identifies Promising Compounds and Potential Drug Targets
March 12, 2008

Scientists using a new drug screening method in Drosophila (fruit flies), have identified several drugs and small molecules that reverse the features of fragile X syndrome -- a frequent form of mental retardation and one of the leading known causes of autism. The discovery sets the stage for developing new treatments for fragile X syndrome.

Archive
Autism Speaks, Science, Latest Research
June 22, 2008

Researchers at UCLA have discovered that an FDA-approved drug reverses the brain dysfunction inflicted by a genetic disease called tuberous sclerosis complex (TSC). Because half of TSC patients also suffer from autism, the findings offer new hope for addressing learning disorders due to autism. The findings were published by Nature Medicine in its June 22 online edition.

Archive
Autism Speaks, Science, Latest Research
Researchers Find Placental Tissue Changes in Individuals with Autism Spectrum Disorders
September 13, 2007
Archive
Autism Speaks, Science, Research, Report: Early Abnormality in Autism - Researchers Find Placental Tissue Changes in Individuals with Autism Spectrum Disorders
June 25, 2008

Autism Speaks, though its Clinical Trial Network (CTN), has long supported research aimed at finding treatments to ease the distress of people with autism. Now the CTN has added two new sites, CRCNJ in Voorhees, New Jersey and AMR-Baber Research in Naperville

Illinois, to the growing list of research centers participating in its Study of Fluoxetine in Autism (SOFIA).

Archive
Autism Speaks, Science, Latest Research
March 09, 2009

In its issue dated March16, 2009, Newsweek published an edited version of letter from Autism Speaks Chief Science Officer Geraldine Dawson about autism and vaccines.

Click here to read the letter as published in Newsweek. The complete letter appears below.

To The Editor,

Archive
Autism Speaks, Science, Latest Research, Geraldine Dawson Letter to Newsweek
September 21, 2009

January 8, 2009

Dear friends,

Archive
Autism Speaks, Science, Latest Research, 2008 Autism Science Achievements of the Year
January 07, 2010

January 7, 2010

Dear friends:

Archive
Autism Speaks, Science, Latest Research, 2008 Autism Science Achievements of the Year